JPMorgan Chase has delivered on its Q2 setup — the stock closed at $342.89 on July 14, up 2.5% on the day, and analysts have responded immediately with a broad round of target upgrades that now pull the consensus mean well above current levels.
The analyst reaction to the Q2 print is the defining story of the week. Six firms raised their price targets on July 15 alone, with no rating downgrades in the mix. Wells Fargo's Mike Mayo moved his target to $375 from $360, maintaining Overweight. Barclays lifted to $420 from $391, also Overweight — the highest target in the group. RBC Capital raised to $370 from $330 with an Outperform. The targets span a wide range, from Baird's cautious $305 (Neutral, raised from $295) to Barclays' $420, which tells you the bull-bear spread on valuation is real. The consensus mean now sits at $362, a gap of roughly 5.6% to the July 14 close. That's tighter than it looks — the stock was already $336 heading into the print, meaning analysts are still collectively chasing price rather than leading it. The bull case, centred on lower credit costs and improving fee income, played out as scripted. The bear case — deposit competition eroding margins and credit normalization ahead — remains the next test for the thesis.
Positioning around the print is notably relaxed, which is consistent with what was documented in previous notes but has now settled further. Short interest has fallen to just under 1% of the free float — 26.1 million shares short as of July 14, down more than 11% on the week and roughly 2.7% lower than a month ago. This is not a crowded short. Borrow is essentially free at 0.27% cost to borrow, easing another 15% on the week. Availability is effectively unconstrained — the lending pool is nowhere near tapped, with availability readings at the ceiling of what the data captures. There is no short squeeze story here, and no meaningful borrow pressure. Options tell a similar story: the put/call ratio at 1.10 is actually slightly below its 20-day average of 1.15, sitting a third of a standard deviation below the mean. Compared to mid-June, when the PCR was running above 1.4, the options market has moved from defensive to relatively neutral. Positioning looks relaxed rather than charged.
The peer picture sharpens the JPMorgan outperformance story. Bank of America added 1.9% on the day and 1.3% on the week — directionally aligned. But Citigroup dropped 5.3% on the day and 5.3% on the week, and Wells Fargo fell 2.7% on the day, suggesting the Q2 reporting season is producing divergent outcomes across the group. JPMorgan is clearly in the top tier of post-earnings reactions this cycle.
Factor scores are constructive but not extreme. The dividend score ranks at the 94th percentile, and the days-to-cover rank is at the 84th percentile — both reflecting the low short interest environment. The 12-month forward EPS momentum ranks at the 76th percentile, and the earnings surprise rank at the 73rd percentile, consistent with a bank that consistently delivers above expectations. The ORTEX short score has drifted lower all week, from 31.3 on July 6 to 30.3 on July 14, reflecting the reduction in short positioning. Valuation multiples are ticking higher with the stock: the trailing P/E has expanded to 14.5, up around 1.1 points over the past 30 days, and price-to-book now runs at 2.4x, up 0.18 over the same period.
The next scheduled earnings event is October 13. Between now and then, the questions are whether credit cost tailwinds persist into Q3, whether deposit competition pressure materialises in the net interest income line, and whether the analyst community — which has now moved targets up sharply on both sides of the Q2 print — keeps pace with a stock that has gained more than 15% since its June lows.
See the live data behind this article on ORTEX.
Open JPM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
